Select the type of procedure
21081042
1
Enquiry period
with
23.05.2023 16:42
to 05.06.2023 11:00
to 05.06.2023 11:00
2
Bidding period
with
05.06.2023 11:00
to 27.07.2023 14:00
to 27.07.2023 14:00
3
Auction
will not be used
4
Evaluation
5
Contract
Status
Evaluation
Estimated value without VAT
161 428 145,78 MDL
Period of clarifications:
23 May 2023, 16:42 - 5 Jun 2023, 11:00
Submission of proposals:
5 Jun 2023, 11:00 - 27 Jul 2023, 14:00
Supplier technical support:
(+373) 79999801
This procedure is carried out without auction. Your offer is final and must contain the entire list of required documents.
Subscribe impossible
during the period Evaluation
“Achiziționarea medicamentelor necesare instituțiilor medico-sanitare publice (IMSP) și instituțiilor bugetare care prestează servicii medicale și sociale pentru anul 2024 (Lista de bază, partea II)”
Information about customer
Fiscal code/IDNO
Address
MD-2009, MOLDOVA, mun.Chişinău, locality, MD-2009, Republica Moldova, Chişinău str. Cosmescu 3
Web site
---
The contact person
Purchase data
Date created
23 May 2023, 16:03
Date modified
23 May 2023, 16:42
Achizitii.md ID
21081042
MTender ID
CPV
33600000-6 - Produse farmaceutice
Type of procedure
Open tender
Award criteria
The lowest price
Funding sources
List of lots
Lot nr. 7 - Iopromidum 623,40 mg/ml 100 ml
Budget: 1148127.27 MDL
Purchase has not taken place
Lot nr. 13 - Irbesartanum + Hydrochlorothiazidum 300 mg+12.5 mg
Budget: 17011.59 MDL
Active
Lot nr. 20 - Kalii aspartas + Magnesii aspartas 158-250 mg + 140-250 mg
Budget: 318144.55 MDL
Purchase has not taken place
Lot nr. 21 - Kalii aspartas + Magnesii aspartas 452 mg+400 mg/10 ml
Budget: 1067022.0 MDL
Active
Lot nr. 29 - Ketorolacum/Ketorolacum tromethaminum 30 mg/1 ml
Budget: 254032.13 MDL
Active
Lot nr. 32 - Lactobacillus acidophilus+Bifidobacterium infantis+Enterococcus faecium 1.2 x10^7 CFU (280 mg)
Budget: 2464652.41 MDL
Active
Lot nr. 41 - Levocarnitinum 100 mg/ml 10 ml
Budget: 80990.8 MDL
Purchase has not taken place
Lot nr. 49 - Levomepromazinum 25 mg/1 ml
Budget: 109507.15 MDL
Purchase has not taken place
Lot nr. 63 - Lisinoprilum+Hydrochlorthiazidum 10 mg+12.5 mg
Budget: 18196.93 MDL
Purchase has not taken place
Lot nr. 67 - L-ornitina-L-aspartat/Ornithinum/Ornithinum aspartatum 500 mg/ml
Budget: 293460.0 MDL
Active
Lot nr. 69 - Lornoxicamum 8 mg, pulb./sol. inj. sau pulb.+solv./sol. inj.
Budget: 629922.56 MDL
Active
Lot nr. 73 - Magnesii lactas/citras + Pyridoxinum 100 mg+10 mg
Budget: 622839.93 MDL
Active
Lot nr. 74 - Magnesii lactas+Magnesii pidolas+Pyridoxinum 100 mg+10 mg/10 ml
Budget: 201420.83 MDL
Active
Lot nr. 94 - Metamizoli natrium + Pitofenonum + Fenpiverini bromidum 500 mg+2 mg+0.02 mg/ml 5 ml
Budget: 655226.04 MDL
Active
Lot nr. 101 - Methoxy polyethylene glycol-epoetin beta 50 mcg/0.3 ml
Budget: 70205.68 MDL
Purchase has not taken place
Lot nr. 110 - Metoclopramidum/Metoclopramidi hydrochloridum 10 mg/2 ml
Budget: 394083.6 MDL
Active
Lot nr. 116 - Metronidazolum 500 mg, comprimate vaginale/ovule
Budget: 24753.75 MDL
Active
Lot nr. 119 - Metronidazolum+Chlorhexidinum 10 mg+0.5 mg/g 20 g
Budget: 22594.05 MDL
Active
Lot nr. 123 - Misoprostolum 200 mcg, comprimate
Budget: 191467.84 MDL
Purchase has not taken place
Lot nr. 130 - Moxifloxacinum 400 mg in volume de 100 ml sau 250 ml
Budget: 537009.26 MDL
Active
Lot nr. 148 - Natrii chloridum+Kalii chloridum+Calcii chloridum (analog Ringer) 0,86 g+0,03 g+0,033 g/100 ml 400 ml-500 ml
Budget: 3692773.26 MDL
Active
Lot nr. 149 - Natrii chloridum+Kalii chloridum+Calcii chloridum (analog Ringer) 0.86 g+0.03 g+0.033 g/100 ml 200 ml
Budget: 1872780.0 MDL
Active
Lot nr. 150 - Natrii chloridum+Kalii chloridum+Calcii chloridum+Natrii lactas 500 ml
Budget: 1293677.01 MDL
Active
Lot nr. 151 - Natrii chloridum+Kalii chloridum+Kalii (Natrii) citras+Glucosum -
Budget: 469000.0 MDL
Active
Lot nr. 152 - Natrii chloridum+Kalii chloridum+Natrii acetas (analog Acesol) 5 mg+1mg+2 mg/ml 400 ml
Budget: 82137.91 MDL
Active
Lot nr. 158 - Neomycinum+Polymyxini B sulfas+Nystatinum 35000 UI+35000 UI+100000 UI
Budget: 32243.96 MDL
Active
Lot nr. 170 - Nitroglycerinum 5 mg/ml 2 ml
Budget: 75808.0 MDL
Purchase has not taken place
Lot nr. 192 - Pancreatinum (Lipasum + Amylasum + Proteasum) 10000 UI (U-Fe/UA) lipaza
Budget: 658539.2 MDL
Active
Lot nr. 193 - Pancreatinum (Lipasum+Amylasum+Proteasum) 3500 U+4200 U+250 U
Budget: 631784.23 MDL
Active
Lot nr. 194 - Pantoprazolum 40 mg, comprimate gastrorezistente/capsule.
Budget: 104831.1 MDL
Active
Lot nr. 206 - Paracetamolum + Chlorphenaminum + Pseudoephedrinum 100 ml
Budget: 14424.95 MDL
Active
Lot nr. 213 - Perindoprilum argininum + Indapamidum 5 mg+1.25 mg
Budget: 36062.23 MDL
Active
Lot nr. 252 - Rabeprazolum 20 mg, Comprimate gastrorezistente/Capsule gastrorezistente.
Budget: 53421.31 MDL
Active
Lot nr. 256 - Reosorbilact/Resorbilon (sau echivalentul) 200 ml
Budget: 2153107.58 MDL
Active
Lot nr. 258 - Retinolum 50000 UI/ml 10 ml
Budget: 3547.16 MDL
Purchase has not taken place
Lot nr. 259 - Retinolum+Tocoferolum/Retinoli palmitas + Tocopheroli acetas 100000 UI+100 mg
Budget: 208459.37 MDL
Purchase has not taken place
Lot nr. 294 - Sulfamethoxazolum+Trimethoprimum 200 mg+40 mg/5 ml 80 ml
Budget: 32930.01 MDL
Active
Lot nr. 298 - Sulphocamphocainum 10% 2 ml
Budget: 12133.2 MDL
Purchase has not taken place
Lot nr. 329 - Tramadolum + Dexketoprofenum 75 mg+25 mg
Budget: 170027.03 MDL
Purchase has not taken place
Lot nr. 345 - Valeriana officinalis L./Valerianae radicis extractum siccum 20 mg-30 mg
Budget: 44416.56 MDL
Purchase has not taken place
Lot nr. 352 - Vancomycinum/Vancomycinum hydrochloridum 1000 mg
Budget: 1510129.86 MDL
Purchase has not taken place
Lot nr. 353 - Vancomycinum/Vancomycinum hydrochloridum 500 mg
Budget: 288594.8 MDL
Purchase has not taken place
Lot nr. 354 - Venlafaxinum 37,5 mg, capsule cu eliberare prelungita.
Budget: 15390.56 MDL
Active
Lot nr. 356 - Venlafaxinum 75 mg, capsule cu eliberare prelungita
Budget: 6341.21 MDL
Active
Lot nr. 366 - Xeroformium+Pix liquida (analog Wishnevsky) 30 mg/30 mg/g 40 g
Budget: 125304.0 MDL
Active
Only authorized platform users may ask questions during the clarification period.
Document successfully signed
OK